The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemiaHannah Lawson, Kamil R. Kranc, Paolo Gallipoli et al.|Nature Cancer|2024Cited by 40